tirzepatide and breast cancer 🚨Scientists found an FDA-approved druge that shrinks tumors! In an unexpected promising discovery, researchers have found that tirzepatide, a drug approved for diabetes and weight loss under the names New study links GLP-1 drugs

GLP-1 medications mimic this hormone to: Slow gastric emptying (helping you feel fuller longer) Manage appetite and reduce cravings Improve insulin response Support fat loss and metabolic health These medications are clinically backed and widely used to help individuals manage weight, stabilize blood sugar, and reduce obesity-related risk factors

Cost alone does not reflect clinical value

Patients should be advised to respond promptly to the urge to defecate and to allocate sufficient time for bowel movements, ideally after meals when the gastrocolic reflex is most active

What percentage of body weight can be lost with retatrutide compared to tirzepatide

Washington University said that people who interrupted GLP1 treatment and then resumed saw an average 12 percent risk reduction, versus 18 percent with continuous use, and that restarting the medication helped restore some protection, but only partially. CNBC likewise reported that the impact may not be fully reversible. Ziyad AlAly, senior author and epidemiologist at Washington University and the VA Saint Louis Health Care System, framed the pattern starkly